Dawnrays Pharmaceutical (Holdings) logo

2348 - Dawnrays Pharmaceutical (Holdings) News Story

HK$1.11 0.0  0.9%

Last Trade - 1:56am

Sector
Healthcare
Size
Small Cap
Market Cap £159.1m
Enterprise Value £106.2m
Revenue £108.3m
Position in Universe 2250th / 5957

BRIEF-Dawnrays Pharmaceutical says HY revenue was up 17.4 percent

Tue 22nd August, 2017 5:10am
Aug 22 (Reuters) - Dawnrays Pharmaceutical (Holdings) Ltd 
 2348.HK : 
    * Declares an interim dividend of HK$0.03 per share for year 
ending 31 December 2017 
    * HY profit for the period attributable to owners of the 
parent RMB149mln, up 13.3 percent 
    * HY revenue RMB491.1 million, up  17.4 percent 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nNRA4cmcqf 
Further company coverage:  2348.HK  
 
 ((Bangalore.newsroom@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.